AI assistant
HIKMA Pharmaceuticals PLC — Director's Dealing 2020
Feb 28, 2020
4841_dirs_2020-02-28_26dd4f31-696e-46df-86ff-7f233601aab9.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 5272E
Hikma Pharmaceuticals Plc
28 February 2020
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Said Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Chairman |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin. The Executive Chairman is a director of and shareholder in Darhold Limited with an equity interest of 21.99%. |
| c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,000,000 |
| d) | Aggregated information | Aggregated volume: 1,000,000 Price: £0.00p |
| e) | Date of the transaction | 28 February 2020 |
| f) | Place of the transaction | Amman |
Mazen Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Mazen Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Vice Chairman |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 11.08%. |
| c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,000,000 |
| d) | Aggregated information | Aggregated volume: 1,000,000 Price: £0.00p |
| e) | Date of the transaction | 28 February 2020 |
| f) | Place of the transaction | Amman |
Mohammed 'Ali' Al-Husry
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Mohammed 'Ali' Al-Husry |
| 2 | Reason for the notification | |
| a) | Position/status | Non-Executive Director |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.13%. |
| c) | Price(s) and volume(s) | Price(s): £0.00p Volume(s): 1,000,000 |
| d) | Aggregated information | Aggregated volume: 1,000,000 Price: £0.00p |
| e) | Date of the transaction | 28 February 2020 |
| f) | Place of the transaction | Amman |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBDGDDXDDDGGI